JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the issuance of Auto Callable Contingent Interest Notes linked to the MerQube US Large-Cap Vol Advantage Index, with a maturity date of July 9, 2027. The notes, designed for investors seeking contingent interest payments based on the performance of the index, will be automatically called if the index's closing level on any review date, excluding the first through eleventh and final review dates, is at or above its initial value. The earliest an automatic call can be initiated is July 7, 2025. The notes carry risks including the potential loss of principal and the possibility that no contingent interest payments may be made. The index includes a...Show More

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the issuance of Auto Callable Contingent Interest Notes linked to the MerQube US Large-Cap Vol Advantage Index, with a maturity date of July 9, 2027. The notes, designed for investors seeking contingent interest payments based on the performance of the index, will be automatically called if the index's closing level on any review date, excluding the first through eleventh and final review dates, is at or above its initial value. The earliest an automatic call can be initiated is July 7, 2025. The notes carry risks including the potential loss of principal and the possibility that no contingent interest payments may be made. The index includes a 6.0% per annum daily deduction, which will affect its performance. The notes are unsecured and unsubordinated obligations of JPMorgan Financial, guaranteed by JPMorgan Chase & Co., and subject to their credit risks. The notes are expected to price on or about July 5, 2024, and settle on or about July 10, 2024. Investing in the notes involves a number of risks detailed in the accompanying prospectus supplement and other offering documents. The Securities and Exchange Commission has not approved or disapproved the notes, nor have they passed upon the accuracy or adequacy of the pricing supplement or the accompanying documents.